Comparison of inhaled beclomethasone and budesonide. Patients do not take prescribed doses.
作者信息
Cates C
出版信息
BMJ. 1999 Jul 10;319(7202):124-5; author reply 126. doi: 10.1136/bmj.319.7202.124a.
Abstract
摘要
相似文献
1
Comparison of inhaled beclomethasone and budesonide. Patients do not take prescribed doses.吸入性倍氯米松与布地奈德的比较。患者未服用规定剂量。
BMJ. 1999 Jul 10;319(7202):124-5; author reply 126. doi: 10.1136/bmj.319.7202.124a.
2
Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records.新西兰吸入用倍氯米松和布地奈德效力比较：基于计算机化全科医疗记录的回顾性研究
BMJ. 1998 Oct 10;317(7164):986-90. doi: 10.1136/bmj.317.7164.986.
3
Comparison of inhaled beclometasone and budesonide. Back titration of inhaled steroids is uncommon in New Zealand.
BMJ. 1999 Jul 10;319(7202):125; author reply 126.
4
Differences in the potencies of inhaled steroids are not reflected in the doses prescribed in primary care in New Zealand.吸入性类固醇药物效力的差异在新西兰初级医疗保健所开的处方剂量中并未体现出来。
Eur J Clin Pharmacol. 2000 Aug;56(5):431-5. doi: 10.1007/s002280000140.
5
Differential prescribing of inhaled corticosteroids in New Zealand general practice.新西兰全科医疗中吸入性糖皮质激素的差异化处方
N Z Med J. 2003 Aug 22;116(1180):U563.
6
Effects of short-term inhaled budesonide and beclomethasone dipropionate on serum osteocalcin in premenopausal women.短期吸入布地奈德和丙酸倍氯米松对绝经前女性血清骨钙素的影响。
Am Rev Respir Dis. 1993 Jul;148(1):113-5. doi: 10.1164/ajrccm/148.1.113.
7
Effects of inhaled corticosteroids on bone.吸入性糖皮质激素对骨骼的影响。
Neth J Med. 1998 Jan;52(1):48-9. doi: 10.1016/s0300-2977(97)00093-4.
8
The effects of inhaled glucocorticoids on bone mass and biochemical markers of bone homeostasis: a 1-year study of beclomethasone versus budesonide.吸入性糖皮质激素对骨量及骨稳态生化标志物的影响：倍氯米松与布地奈德的1年研究
Neth J Med. 1997 Jun;50(6):233-7. doi: 10.1016/s0300-2977(96)00081-2.
9
Comparison of inhaled beclomethasone and budesonide. Study was inadequate.吸入用倍氯米松与布地奈德的比较。研究不充分。
BMJ. 1999 Jul 10;319(7202):125-6; author reply 126.
10
Efficacy of inhaled beclomethasone dipropionate and budesonide in the treatment of asthma.吸入用丙酸倍氯米松和布地奈德治疗哮喘的疗效。
Respir Med. 1998 Jul;92 Suppl B:7-14. doi: 10.1016/s0954-6111(98)90435-8.
引用本文的文献
1
Using education to improve control of asthma in children.利用教育改善儿童哮喘控制情况。
CMAJ. 2009 Sep 1;181(5):248-9. doi: 10.1503/cmaj.091120. Epub 2009 Aug 17.
2
Delayed prescriptions in primary care.基层医疗中的延迟处方。
Br J Gen Pract. 2003 Nov;53(496):836-7.
本文引用的文献
1
Efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI in Japanese patients with moderately persistent asthma.
Respirology. 2001 Mar;6(1):27-35. doi: 10.1046/j.1440-1843.2001.00293.x.
2
Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide.吸入用丙酸倍氯米松和布地奈德的比较物理化学和药代动力学特征
Respir Med. 1998 Jul;92 Suppl B:2-6. doi: 10.1016/s0954-6111(98)90434-6.
3
Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records.新西兰吸入用倍氯米松和布地奈德效力比较：基于计算机化全科医疗记录的回顾性研究
BMJ. 1998 Oct 10;317(7164):986-90. doi: 10.1136/bmj.317.7164.986.
4
Efficacy and safety of inhaled corticosteroids. New developments.吸入性糖皮质激素的疗效与安全性。新进展。
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 2):S1-53. doi: 10.1164/ajrccm.157.3.157315.
5
Clinical efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI with volumatic spacer. A 2-year randomized study in 102 asthma patients.布地奈德都保与丙酸倍氯米松定量气雾剂加储雾罐的临床疗效比较：一项针对102例哮喘患者的2年随机研究。
Allergy. 1994 Dec;49(10):833-6. doi: 10.1111/j.1398-9995.1994.tb00783.x.
Zotero 插件